Celsius stock surges on strong sales, profit growth Nov. 09, 2022 5:22 PM ETCelsius Holdings, Inc. (CELH) Aaron Davidson/Getty Images Entertainment Celsius Holdings (NASDAQ:CELH) shares rose sharply in Wednesday’s extended session after reporting triple-digit gains in profits and sales for the first 9 months of 2022. The Florida-based energy drink company posted $188.2M in revenue, well above estimates, and $78.7M in gross profit. The results bring total revenue in 2022 to $475.6M, up 126% from the prior year, and gross profits to $191.9M, up 122% from 2021. Management added that third quarter results were “negatively impacted by a $155.4M expense in Sales and Marketing related to a termination expense of prior distributors recognized,” skewing EPS figures.
Celsius Holdings, Inc. (CELH)-- coming back strong-! NasdaqCM - NasdaqCM Real Time Price. 78.65-3.71 (-4.50%) At close: 04:00PM EST 85.78 +7.13 (+9.07%) After hours: 07:09PM EST
Stoney!!! Did you close TWLO yet? I hope you learned your lesson regarding not advising readers to get out. $74 to $44 stung I know.... thank god TSLA didn't drop 42%... plus it went to $236... I gave you an easy 10%!. TWLO has dropped since yor "strong buy" at $74 and hasn't looked back. Fear not however... VZ has your back.... and our readers are still here because of that. Tomorrow's Gummy----> PETQ or MQ? Stoney loved it at $57. Apparently no dd on his part or it wouldn't be $40. I think he still has it too. Twice as bad as TSLA's drop. Must not be one of the 10 in a row huge winners.
Good Morning Stock fans.- The very first SPAC I ever bought or the second was paysafe.- They always had the numbers but never had the respect. Paysafe raises FY22 revenue view to $1.48B-$1.49B from $1.47B-$1.49B 07:02 PSFE IDEA #1-> PSFE $1.20
Janus International Group ups FY22 revenue view to $990M-$1.01B from $940M-$960M 07:05 JBI Janus International Group reports Q3 adjusted EPS 22c consensus 17c 07:04 JBI IDEA #2 JBI $8.50
Solo Brands cuts FY22 revenue growth view to 15%-20% from mid-20% range 06:53 DTC FY22 consensus $504.52M. Adjusted gross margin, as previously guided, is planned to be above 60% of total revenue. Adjusted EBITDA margin as previously guided, is expected to be in the mid-teens as a percentage of total revenue. Cites the latest macro-economic trends and overall consumer unpredictability heading into the holiday season. Solo Brands reports Q3 adjusted EPS 15c, consensus 7c
Ionis Pharmaceuticals price target raised to $31 from $28 at Citi » 06:52 IONS Could of used a larger PT!
Purple Innovation upgraded to Buy from Hold at Craig-Hallum 06:46 PRPL Craig-Hallum analyst Jeremy Hamblin upgraded Purple Innovation to Buy from Hold with a price target of $6, up from $4. Terran Orbital price target raised to $15 from $14 at Canaccord 06:45 LLAP Canaccord analyst Austin… Story Utz Brands raises FY22 revenue growth view to 17%-19% from 13%-15% 06:37 UTZ Consensus for FY22… Clearside Biomedical price target raised to $6 from $5 at H.C. Wainwright 06:26 CLSD Mr Clearside again.... I have been feeling hunchy about this name I profiled it a few times... Hummmm. CLSD vs IONS-?
Yeti CEO says 'expectations for the second half of the year have not changed' 06:14 YETI CEO Matt Reintjes said,… We still expect a fully grown Yeti to emerge from Washington St forests any day......